1.Preliminary results of supported chemotherapy in treatment of operated gastric cancer in Hai Phong (from January, 2001 to June, 2006)
Hoa Lam Nguyen ; Hung Quang Tran
Journal of Surgery 2007;57(1):49-55
Background: Gastric cancer is the second common disease among types of cancer, followed by lung cancer for male and breast cancer for female. The selection of appropriate regimens for illness and economic conditions of patients is always a difficult problem for clinicians. Objectives: To assess preliminary results of chemotherapy in treatment of gastric cancer in Hai Phong. Subjects and method: A longitudinal, cross-section study was conducted on 57 patients with gastric cancer (35 male, 21 female), treated in Viet Tiep hospital from January, 2002 to June, 2006. All of them were in stage of Dukes C, treated postoperative supported chemotherapy. Results: Side effects were common seen as vomit, nausea and diarrhea. They were often mild and disappeared after stopping medication. 30/57 patients responded to treatment. 21 patients were treated with regimen 5FU, however, amount of treatment cycles was very scattered and treatment effect was unclear. 36 patients were treated with multi-chemical regimens as FUFA, FAM and ELF. Their response to treatment was more clearly than regimen 5FU. During treatment, there were 6 patients who had not completely responded to treatment. In which, 4 patients developed more seriously: metastasis to liver, ovary, bone and lung. 2 patients had died. Conclusion: Regimen 5FU had a little toxicity. Regimen FUFA was more effective. The role of chemotherapy in supported treatment was unclear. Chemotherapy could be applied to patients with early stage of Dukes B.
Stomach Neoplasms/ therapy
;
Drug Therapy
;
2.The prognostic value of serial measurement of serum CA-125 levels during chemotherapy of epithelial ovarian cancer.
Soon Beom KANG ; Hye Sung MOON ; Seung Kew BAIK ; Byung Gi KIM ; Yong Sang SONG ; Hyo Pyo LEE
Korean Journal of Obstetrics and Gynecology 1993;36(11):3750-3760
No abstract available.
Drug Therapy*
;
Ovarian Neoplasms*
3.Advanced colorectal cancer: Do we need chemotherapy?.
Korean Journal of Medicine 1999;57(4):732-736
No abstract available.
Colorectal Neoplasms*
;
Drug Therapy*
4.Chemotherapy of Gastric Cancer.
Korean Journal of Medicine 1998;55(4):496-502
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
5.Chemotherapy of Gastric Cancer.
Korean Journal of Medicine 1998;55(4):496-502
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
6.Intraperitoneal Chemotherapy for Gastric Cancer.
Journal of the Korean Gastric Cancer Association 2002;2(1):1-4
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
7.Surgeon's View of Chemotherapy in Gastric Cancer.
Journal of the Korean Gastric Cancer Association 2003;3(4):166-171
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
8.The hematologic toxicity of MFC chemotherapy following surgery for gastric cancer.
Hyo Cheol PARK ; Jae Hong KIM ; Ju Sup PARK
Journal of the Korean Surgical Society 1992;42(2):171-178
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
9.Efficacy of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
The Korean Journal of Gastroenterology 2016;68(5):234-236
No abstract available.
Drug Therapy*
;
Stomach Neoplasms*
10.Recent advances in systemic chemotherapy for metastatic colorectal cancer.
Korean Journal of Medicine 2004;67(4):330-340
No abstract available.
Colorectal Neoplasms*
;
Drug Therapy*
Result Analysis
Print
Save
E-mail